Weak Interaction of the Antimetabolite Drug Methotrexate with a Cavitand Derivative

Int J Mol Sci. 2020 Jun 18;21(12):4345. doi: 10.3390/ijms21124345.

Abstract

Formation of inclusion complexes involving a cavitand derivative (as host) and an antimetabolite drug, methotrexate (as guest) was investigated by photoluminescence measurements in dimethyl sulfoxide solvent. Molecular modeling performed in gas phase reflects that, due to the structural reasons, the cavitand can include the methotrexate in two forms: either by its opened structure with free androsta-4-en-3-one-17α-ethinyl arms or by the closed form when all the androsta-4-en-3-one-17α-ethinyl arms play role in the complex formation. Experiments reflect enthalpy driven complex formation in higher temperature range while at lower temperature the complexes are stabilized by the entropy gain.

Keywords: antirheumatic; cavitand; fluorescence; inclusion complex; methotrexate; thermodynamics.

MeSH terms

  • Antimetabolites / chemistry*
  • Dimethyl Sulfoxide / chemistry
  • Drug Stability
  • Entropy
  • Ethers, Cyclic / chemistry
  • Methotrexate / chemistry*
  • Models, Molecular
  • Molecular Structure
  • Resorcinols / chemistry*
  • Solvents / chemistry
  • Thermodynamics

Substances

  • Antimetabolites
  • Ethers, Cyclic
  • Resorcinols
  • Solvents
  • cavitand
  • Methotrexate
  • Dimethyl Sulfoxide